Athira Pharma Inc. (ATHA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.53
-0.00 (-0.21%)
At close: Jan 14, 2025, 3:59 PM
0.53
-0.09%
After-hours Jan 14, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
PE Ratio | -0.79 | -1.37 | -8.85 | -59.71 | -118.7 | -20.77 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.71 | 0.51 | 1.50 | 4.06 | -28.3 | -7.11 |
P/FCF Ratio | -0.91 | -1.62 | -10.77 | -42.09 | -150.31 | -23.61 |
P/OCF Ratio | -0.92 | -1.65 | -11.16 | -46.14 | -150.31 | -23.61 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | -0.08 | -0.05 |
Quick Ratio | 5.37 | 9.74 | 28.32 | 43.96 | 1.70 | 8.56 |
Current Ratio | 5.37 | 9.68 | 28.07 | 43.66 | 1.70 | 8.56 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -4.28 | -21.34K | -54.48 | -15.75 | -556.56 |
Return on Equity (ROE) | -0.9 | -0.37 | -0.17 | -0.07 | 0.24 | 0.34 |
Return on Assets (ROA) | -0.73 | -0.34 | -0.16 | -0.07 | -2.15 | -1.03 |
Return on Capital (ROIC) | -0.95 | -0.44 | -0.2 | -0.07 | -5.95 | -1.15 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |